Tefinostat
- Generic Name
- Tefinostat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H37N3O5
- CAS Number
- 914382-60-8
- Unique Ingredient Identifier
- ZAU91150SB
- Background
Tefinostat is under investigation in clinical trial NCT02759601 (Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)).
- Associated Conditions
- -
- Associated Therapies
- -
Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2018-12-20
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 69
- Registration Number
- NCT02759601
- Locations
- 🇬🇧
Barts Health NHS Trust, London, Greater London, United Kingdom
🇬🇧Clatterbridge Cancer Centre, Liverpool, United Kingdom
🇬🇧Beatson Cancer Centre, Glasgow, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath